Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Company Overview

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Key Stats

• Today's Range: $5.21 to $7.88
• 50-Day Range: $5.16 to $9.30
• 52-Week Range: $3.50 to $14.30
• Volume: 341,556 shs
• Average Volume: 315,160 shs
• Market Capitalization: $356.61 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ZYBT Stock Analysis - Frequently Asked Questions

How have ZYBT shares performed this year?

Zhengye Biotechnology's stock was trading at $4.86 at the beginning of 2025. Since then, ZYBT stock has increased by 46.1% and is now trading at $7.10.

When did Zhengye Biotechnology IPO?

Zhengye Biotechnology (ZYBT) raised $6 million in an initial public offering (IPO) on Tuesday, January 7th 2025. The company issued 1,500,000 shares at a price of $4.00 per share. Kingswood Capital Partners served as the underwriter for the IPO.

When did Zhengye Biotechnology's lock-up period expire?

Zhengye Biotechnology's lock-up period expired on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its IPO on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Who are Zhengye Biotechnology's major shareholders?

Zhengye Biotechnology's top institutional investors include Geode Capital Management LLC (0.06%).

How do I buy shares of Zhengye Biotechnology?

Shares of ZYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ZYBT
• Previous Symbol: NASDAQ:ZYBT
• CIK: 1975641
• Web: www.jlzybio.com
• Phone: 86-13844801919
• Fax: N/A
• Employees: 278
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 1.31
• Quick Ratio: 0.88

Sales & Book Value

• Annual Sales: $25.53 million
• Price / Sales: 13.97
• Cash Flow: $0.15 per share
• Price / Cash Flow: 50.56
• Book Value: $1.02 per share
• Price / Book: 7.41

Miscellaneous

• Outstanding Shares: 47,170,000
• Free Float: N/A
• Market Cap: $356.61 million
• Optionable: N/A
• Beta: N/A